Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
amylase/inflammation
Lyen an sove nan clipboard la
4 rezilta yo
Use of Aspergillus niger aspergilloglutamic peptidase to improve animal performance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
This application is the U.S. national phase of International Application No. PCT/EP2014/077353 filed 11 Dec. 2014 which designated the U.S. and claims priority to EP 13196583.2 filed 11 Dec. 2013, the entire contents of each of which are hereby incorporated by reference.
BRIEF DESCRIPTION OF THE
Enzyme formulation for reducing histamine intolerance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
Enzyme formulation for reducing histamine intolerance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
Antioxidant agent, and antioxidant cosmetic and UV care cosmetic
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
CROSS-REFERENCE TO RELATED APPLICATIONS
This patent application is the U.S. national phase of International Patent Application No. PCT/JP2016/050042, filed on Jan. 4, 2016, which claims the benefit of Japanese Patent Application No. 2015-001966, filed Jan. 8, 2015, the disclosures of which are
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
